Interbacterial competition assays against <i>Escherichia coli</i> showed significant variations in killing efficacy, with a subset of isolates from the Sgn4 monophyletic lineage exhibiting robust antibacterial activity and increased pathogenicity in a <i>Galleria mellonella</i> infection model. The gene discussed is COPS4; the disease is infection.